Apellis Pharmaceuticals' Chief Commercial Officer Adam Townsend
Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, announced today the appointment of Adam Townsend as Chief Commercial Officer.
Format
JPEG
Source
Apellis Pharmaceuticals, Inc.